Skip to main content
. 2018 Jun 27;5(3):218–222. doi: 10.1016/j.ijnss.2018.06.005

Table 3.

Outcome measures at pre- and post-treatment.

Intention-to-treat (n = 23)
Completers (n = 20)
Pre
(Mean ± SD)
Post
(Mean ± SD)
Improvement (%) ES Pre
(Mean ± SD)
Post
(Mean ± SD)
Improvement (%) ES
BDI-II 23.14 ± 7.56 12.36 ± 8.57 47 1.33∗∗ 23.35 ± 7.78 12.35 ± 8.67 47 1.34∗∗
QIDS-SR 11.91 ± 3.98 6.95 ± 5.04 42 1.09∗∗ 11.60 ± 4.03 6.70 ± 4.92 42 1.09∗∗
RSES 25.80 ± 9.06 31.36 ± 10.20 22 0.58 25.84 ± 9.41 32.06 ± 10.46 24 0.62
SF-36v2
 PCS 50.41 ± 10.77 48.15 ± 10.80 −4 −0.21 49.4 ± 10.77 46.90 ± 10.80 −5 −0.23
 MCS 38.74 ± 9.38 42.60 ± 12.30 10 0.35 38.74 ± 9.72 42.60 ± 12.62 10 0.34
 RCS 26.25 ± 14.97 34.79 ± 12.51 33 0.60 26.30 ± 14.61 35.74 ± 11.38 36 0.72

Note: Higher scores on the BDI-II and QIDS-SR indicate greater pathology or severity of depression. ∗∗P < 0.01.P < 0.05.

BDI-II: Beck depression inventory-II score; ES: Effect size of Cohen's d; QIDS-SR: Quick inventory of depressive symptomatology – self-rated; RSES: Rosenberg self-esteem scale; SF-36v2: MOS 36-item short-form health survey version 2; PCS: Physical component summary; MCS: Mental component summary; RCS: role/social component summary.